AAAAAA
Results: 1-25/27
Authors:
WANNER C
KRAMERGUTH A
GALLE J
Citation: C. Wanner et al., USE OF HMG-COA REDUCTASE INHIBITORS AFTER KIDNEY AND HEART-TRANSPLANTATION - LIPID-LOWERING AND IMMUNOSUPPRESSIVE EFFECTS, Biodrugs, 8(5), 1997, pp. 387-393
Authors:
KONIGER M
GREIBER S
PAVENSTADT H
NAUCK M
SCHOLLMEYER P
WANNER C
KRAMERGUTH A
Citation: M. Koniger et al., VLDL-RECEPTOR MEDIATED LIPOPROTEIN UPTAKE BY GLOMERULAR EPITHELIAL AND MESANGIAL CELLS, Journal of the American Society of Nephrology, 8, 1997, pp. 2325-2325
Authors:
HACK D
KONIGER M
RUMP LC
SCHOLLMEYER P
KRAMERGUTH A
Citation: D. Hack et al., IMMUNOSUPPRESSIVE THERAPIES INFLUENCE RECEPTOR-MEDIATED LIPOPROTEIN UPTAKE AND METABOLISM, Journal of the American Society of Nephrology, 8, 1997, pp. 3063-3063
Authors:
GREIBER S
KRAMERGUTH A
KASTNER S
KONIGER M
SCHOLLMEYER P
WANNER C
Citation: S. Greiber et al., MECHANISMS OF POSTTRANSPLANT HYPERLIPIDEMIA - EFFECTS OF CYCLOSPORINE-A ON LDL-RECEPTOR MESSENGER-RNA AND FUNCTION, Journal of the American Society of Nephrology, 8, 1997, pp. 3316-3316
Authors:
KRAMERGUTH A
QUASCHNING T
PAVENSTADT H
GALLE J
NAUCK M
BAUMSTARK MW
SCHOLLMEYER P
MARZ W
WANNER C
Citation: A. Kramerguth et al., UPTAKE AND METABOLISM OF LIPOPROTEINS FROM PATIENTS WITH DIABETES-MELLITUS TYPE-II BY GLOMERULAR EPITHELIAL-CELLS, Nephrology, dialysis, transplantation, 12(7), 1997, pp. 1336-1343
Authors:
QUASCHNING T
KONIGER M
KRAMERGUTH A
GREIBER S
PAVENSTADT H
NAUCK M
SCHOLLMEYER P
WANNER C
Citation: T. Quaschning et al., RECEPTOR-MEDIATED LIPOPROTEIN UPTAKE BY HUMAN GLOMERULAR CELLS - COMPARISON WITH SKIN FIBROBLASTS AND HEPG2 CELLS, Nephrology, dialysis, transplantation, 12(12), 1997, pp. 2528-2536
Authors:
KRAMERGUTH A
BUSCH GL
KABA NK
SCHWEDLER S
WANNER C
LANG F
Citation: A. Kramerguth et al., EFFECT OF OSMOLARITY ON LDL BINDING AND INTERNALIZATION IN HEPATOCYTES, American journal of physiology. Cell physiology, 42(4), 1997, pp. 1409-1415
Authors:
HUBERLANG M
FISCHER KG
GLOY J
SCHOLLMEYER P
KRAMERGUTH A
GREGER R
PAVENSTADT H
Citation: M. Huberlang et al., UTP AND ATP INDUCE DIFFERENT MEMBRANE VOLTAGE RESPONSES IN RAT MESANGIAL CELLS, American journal of physiology. Renal, fluid and electrolyte physiology, 41(6), 1997, pp. 704-711
Authors:
WANNER C
GREIBER S
KRAMERGUTH A
HEINLOTH A
GALLE J
Citation: C. Wanner et al., LIPIDS AND PROGRESSION OF RENAL-DISEASE - ROLE OF MODIFIED LOW-DENSITY-LIPOPROTEIN AND LIPOPROTEIN(A), Kidney international, 1997, pp. 102-106
Authors:
BARTENS W
KRAMERGUTH A
WANNER C
Citation: W. Bartens et al., CORTICOTROPIN INCREASES THE RECEPTOR-SPECIFIC UPTAKE OF NATIVE LOW-DENSITY-LIPOPROTEIN (LDL) - BUT NOT OF OXIDIZED LDL AND NATIVE OR OXIDIZED LIPOPROTEIN(A) [LP(A)] - IN HEPG2 CELLS - NO EVIDENCE FOR LP(A) CATABOLISM VIA THE LDL-RECEPTOR, Metabolism, clinical and experimental, 46(7), 1997, pp. 726-729
Authors:
HOFFMANN MM
NAUCK MS
KRAMERGUTH A
SCHOLLMEYER P
MARZ W
WIELAND H
Citation: Mm. Hoffmann et al., CHARACTERIZATION OF A NEW IN FRAME DELETION APO E4 VARIANT, APO E4-FRIDINGEN, ASSOCIATED WITH HYPERLIPIDEMIA, Atherosclerosis, 134(1-2), 1997, pp. 69-69
Authors:
KRAMERGUTH A
QUASCHNING T
GALLE J
BAUMSTARK MW
KONIGER M
NAUCK M
SCHOLLMEYER P
MARZ W
WANNER C
Citation: A. Kramerguth et al., STRUCTURAL AND COMPOSITIONAL MODIFICATIONS OF DIABETIC LOW-DENSITY LIPOPROTEINS INFLUENCE THEIR RECEPTOR-MEDIATED UPTAKE BY HEPATOCYTES, European journal of clinical investigation, 27(6), 1997, pp. 460-468
Authors:
BISSE E
HUAMANGUILLEN P
HORTH P
BUSSEGRAWITZ A
LIZAMA M
KRAMERGUTH A
HAEHNEL W
WIELAND H
Citation: E. Bisse et al., HETEROGENEITY OF HEMOGLOBIN A(1D) - ASSESSMENT AND PARTIAL CHARACTERIZATION OF 2 NEW MINOR HEMOGLOBINS, A(1D3A) AND A(1D3B), INCREASED IN UREMIC AND DIABETIC-PATIENTS, RESPECTIVELY, Journal of chromatography B. Biomedical applications, 687(2), 1996, pp. 349-356
Authors:
ANDING K
KRUMME B
GREINER S
KELLER E
SCHOLLMEYER P
KRAMERGUTH A
Citation: K. Anding et al., INFECTIONS IN ADULT NEPHROTIC SYNDROME, Journal of the American Society of Nephrology, 7(9), 1996, pp. 339-339
Authors:
KRAMERGUTH A
GALLE J
ANDRE M
ALBRECHT S
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., RECEPTOR-MEDIATED UPTAKE OF NATIVE AND MODIFIED LOW-DENSITY LIPOPROTEINS (LDL) BY HUMAN MESOTHELIAL CELLS AND PERITONEAL-MACROPHAGES, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2165-2165
Authors:
SCHWERTFEGER E
GROTZ W
KRAMERGUTH A
SCHOLLMEYER P
RUMP LC
Citation: E. Schwertfeger et al., A PROSPECTIVE CONTROLLED 1-YEAR STUDY OF SANDIMMUNE NEORAL IN RENAL-TRANSPLANTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3381-3381
Authors:
GREIBER S
KRAMERGUTH A
PAVENSTADT H
GUTENKUNST M
SCHOLLMEYER P
WANNER C
Citation: S. Greiber et al., EFFECTS OF LIPOPROTEIN(A) ON MESANGIAL CELL-PROLIFERATION AND VIABILITY, Nephrology, dialysis, transplantation, 11(5), 1996, pp. 778-785
Authors:
WANNER C
KRAMERGUTH A
NAUCK M
QUASCHNING T
PAVENSTADT H
SCHOLLMEYER P
Citation: C. Wanner et al., CHOLESTEROL-METABOLISM IN GLOMERULAR CELLS - EFFECT OF LIPOPROTEINS FROM NEPHROTIC PATIENTS, Mineral and electrolyte metabolism, 22(1-3), 1996, pp. 39-46
Authors:
NAUCK M
KRAMERGUTH A
BARTENS W
MARZ W
WIELAND H
WANNER C
Citation: M. Nauck et al., IS THE DETERMINATION OF LDL CHOLESTEROL ACCORDING TO FRIEDEWALD ACCURATE IN CAPD AND HD PATIENTS, Clinical nephrology, 46(5), 1996, pp. 319-325
Authors:
KRAMERGUTH A
QUASCHNING T
GREIBER S
WANNER C
Citation: A. Kramerguth et al., POTENTIAL ROLE OF LIPIDS IN THE PROGRESSION OF DIABETIC NEPHROPATHY, Clinical nephrology, 46(4), 1996, pp. 262-265
Authors:
KRAMERGUTH A
GREIBER S
PAVENSTADT H
QUASCHNING T
WINKLER K
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., INTERACTION OF NATIVE AND OXIDIZED LIPOPROTEIN(A) WITH HUMAN MESANGIAL CELLS AND MATRIX, Kidney international, 49(5), 1996, pp. 1250-1261
Authors:
KRAMERGUTH A
NAUCK M
QUASCHNING T
PAVENSTADT H
WIELAND H
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., VLDL AND LDL METABOLISM IN HUMAN AND RAT MESANGIAL CELLS, Nephron, 74(2), 1996, pp. 378-385
Authors:
BARTENS W
NAUCK M
KRAMERGUTH A
GREIBER S
GALLE J
SCHOLLMEYER P
WANNER C
Citation: W. Bartens et al., INFLUENCE OF APOPROTEIN-E PHENOTYPE ON LIPOPROTEIN(A) LEVEL AND LIPIDPROFILE IN PATIENTS WITH THE NEPHROTIC SYNDROME, Journal of the American Society of Nephrology, 6(3), 1995, pp. 381-381
Authors:
KRAMERGUTH A
KELLER M
SCHOMIG M
BAUMSTARK MW
THIERY J
MARZ W
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., UPTAKE OF LDL FROM NORMOTRIGLYCERIDEMIC AND HYPERTRIGLYCERIDEMIC HEMODIALYSIS-PATIENTS HEPATOMA-CELLS AND MACROPHAGES, Journal of the American Society of Nephrology, 6(3), 1995, pp. 544-544
Authors:
KRAMERGUTH A
SCHOMIG M
KELLER M
BAUMSTARK MW
THIERY J
MARZ W
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., INCREASED ATHEROGENIC RISK OF DIABETIC-PATIENTS UNDERGOING HEMODIALYSIS - ROLE OF MODIFIED, TRIGLYCERIDE-RICH LIPOPROTEINS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 544-544